JPRN-UMIN000036756招募中未知
A prospective clinical registry study of genetic profiling and targeted therapies in patients with rare hematologic malignancies; MASTER KEY HEM Protocol - Marker Assisted Selective ThErapy in Rare cancers: Knowledge database Establishing registrY Protocol for hematologic malignancy; MASTER KEY HEM Protocol
ational Cancer Center0 个研究点目标入组 500 人开始时间: 2019年5月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with complications of psychiatric disorders/symptoms that interfere daily life are considered to hamper their participation in the study.
研究者
相似试验
招募中
不适用
A prospective clinical registry study of genetic profiling and targeted therapies in patients with rare cancers; MASTER KEY ProtocolJPRN-UMIN000027552ational Cancer Center1,000
尚未招募
不适用
Clinical and genetic analysis of patients with primary failure of eruption (PFE) and their relativesK00.8Other disorders of tooth developmentDRKS00028019CharitéCentrum für Zahn-, Mund- und Kieferheilkunde CC 330
招募中
不适用
A prospective clinical registration study on the real world efficacy of Angong Niuhuang PillICD-10????:I64.04strokeITMCTR2200005593Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine
招募中
不适用
A prospective epidemiological study for patients with pneumonia in a single center in Japacommunity-acquired pneumonia(CAP),nursing &healthcare-associated pneumonia(NHCAP),hospital-acquired pneumonia(HAP),ventilator-associated pneumonia(VAP)JPRN-UMIN000004353Dept. of Respiratory Medicine, Kurashiki Central Hospital2,000
尚未招募
不适用
A Natural History Study of Patients with Genetically Confirmed Primary Hyperoxaluria Type 3 with a History of Stone EventsPrimary Hyperoxaluria type 3LBCTR2021054742Dicerna Pharmaceuticals, Inc.1